Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 178 participants.

Also called NCT07909915

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 178 participants (planned count) (from the registry)
Sponsor
Rehman Medical Institute - RMI (from the registry)
Registry
  • NCT NCT07909915
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07909915. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease
Condition
Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
Condition
Stroke (CVA) or TIA (transient ischemic attack)
Condition
Cardio Vascular Disease
Intervention (Drug)
Dose adjustment of statins
Intervention (Drug)
no dose adjustment
Lead sponsor
Rehman Medical Institute - RMI (class: other)

Record details

Record id
cardio:ct-nct07909915
Content hash
f5aed13ea2ac0e33c72b9172b7f9ff497e523c27162db1747041e9a37669d7dc